Skip to content

vTv Therapeutics Inc.: filings

Every vTv Therapeutics Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 44 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-06fiscal Q2 202624710001641489-26-000030
10-Q2026-05-13fiscal Q1 202623480001641489-26-000020
10-K2026-03-10fiscal FY 202531840001641489-26-000010
10-Q2025-11-06fiscal Q3 202526780001641489-25-000060
10-Q2025-08-12fiscal Q2 202525760001641489-25-000053
10-Q2025-05-15fiscal Q1 202526550001641489-25-000026
10-K2025-03-20fiscal FY 2024401040001641489-25-000014
10-Q2024-11-12fiscal Q3 202431870001641489-24-000075
10-Q2024-08-08fiscal Q2 202430870001641489-24-000061
10-Q2024-05-09fiscal Q1 202430650001641489-24-000029
10-K2024-03-13fiscal FY 2023401070001641489-24-000012
10-Q2023-11-09fiscal Q3 202333950001641489-23-000070
10-Q2023-08-11fiscal Q2 202333950001641489-23-000053
10-Q2023-05-11fiscal Q1 202331670001641489-23-000021
10-K2023-03-06fiscal FY 2022401060001641489-23-000008
10-Q2022-11-10fiscal Q3 202234970001641489-22-000015
10-Q2022-08-15fiscal Q2 202234970001641489-22-000008
10-Q2022-05-12fiscal Q1 202232630001564590-22-019652
10-K2022-03-29fiscal FY 202141990001564590-22-012258
10-Q2021-11-09fiscal Q3 202133930001564590-21-055468
10-Q2021-08-04fiscal Q2 202133890001564590-21-040889
10-Q2021-05-05fiscal Q1 202132640001564590-21-024121
10-K2021-02-24fiscal FY 2020411000001564590-21-008149
10-Q2020-11-05fiscal Q3 202034920001564590-20-051377
10-Q2020-08-03fiscal Q2 202033910001564590-20-035526
10-Q2020-05-07fiscal Q1 202031640001564590-20-022936
10-K2020-02-21fiscal FY 2019421410001564590-20-005627
10-Q2019-10-30fiscal Q3 201934910001564590-19-038844
10-Q2019-07-31fiscal Q2 201933910001564590-19-027516
10-Q2019-05-01fiscal Q1 201932620001564590-19-014845
10-K2019-02-26fiscal FY 2018391390001564590-19-004516
10-Q2018-11-08fiscal Q3 201832820001564590-18-028660
10-Q2018-08-03fiscal Q2 201832820001564590-18-019035
10-Q2018-05-15fiscal Q1 201826510001564590-18-013639
10-K2018-02-27fiscal FY 201729990001564590-18-003515
10-Q2017-11-01fiscal Q3 201726700001564590-17-020807
10-Q2017-08-02fiscal Q2 201726700001564590-17-014946
10-Q2017-05-03fiscal Q1 201726510001564590-17-008420
10-K2017-02-24fiscal FY 201629980001564590-17-002317
10-Q2016-11-03fiscal Q3 201624650001564590-16-027390
10-Q2016-08-02fiscal Q2 201624630001564590-16-022075
10-Q2016-05-13fiscal Q1 201624470001564590-16-019300
10-K2016-03-04fiscal FY 201530960001564590-16-014035
10-Q2015-11-13fiscal Q3 201526670001193125-15-376707

1 further filing tags fewer than eight published concepts and has no page.

Inspect the source

Entity
vTv Therapeutics Inc. / CIK 0001641489
Captured
2026-09-21T17:22:28.839Z
SEC response SHA-256
a4077830f75ab31b4bd255a2506ae68d2ee3fea6951db63b4abf956f42ed7e7d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001641489.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))